Kevin Weil's Warp Sciences raises $215 million to automate drug discovery labs with robots

Former OpenAI science lead Kevin Weil has launched Warp Sciences, which raised $215 million at an $865 million valuation in a round led by Lightspeed. Chemists wearing cameras and sensor gloves will teach robots to synthesize and test compounds around the clock, work that biotech firms often outsource abroad.

Summary written by DroidBazaar. The original article belongs to its publisher.